Swiss Re Insurance-Linked Fund Management

Original Risk: A Society for Change Agents

EXOR acquires PartnerRe for $6.9 billion


Finally it’s over. The three-way reinsurance merger and acquisitions battle between PartnerRe, AXIS Capital and Italian investment holding company EXOR S.p.A. has reached its conclusion, with EXOR coming out the winner.

EXOR logoIt’s just been announced that EXOR and PartnerRe have signed an agreement which will see the Italian investment group buying the reinsurance firm at a valuation of $6.9 billion, leaving re/insurer AXIS Capital out in the cold.

The agreement will see EXOR acquiring all of the outstanding common shares of PartnerRe for $137.50 per share in cash plus a $3.00 per share special dividend, resulting in a cost of $140.50 per share, and valuing the reinsurance firm at approximately $6.9 billion.

The amalgamation agreement between PartnerRe and AXIS Capital, which had been well into its implementation phase as integration activities had been ongoing for some weeks, has now been terminated, leaving AXIS Capital to benefit from a $315 million termination fee paid by PartnerRe.

PartnerRe preferred shareholders will also receive the enhancements announced earlier this month as part of the terms of the EXOR transaction.

John Elkann, Chairman and CEO of EXOR, commented on the announcement; “Today’s agreement is very positive for PartnerRe and EXOR. Under our stable and committed ownership, PartnerRe will continue to develop as a leading independent global reinsurer.

“EXOR looks forward to working with the Board of Directors and the management of PartnerRe to ensure a successful path forward. I would like to thank our fellow shareholders for their continuing support over recent months.”

The agreement includes a “go-shop” period during which the PartnerRe board is entitled to solicit and evaluate any competing offers to the EXOR transaction and will be allowed to enter into negotiations related to any such proposals received prior to September 14th 2015.

PartnerRe shareholders will have to approve the transaction, which seems likely at this stage, at a special general meeting to be called as soon as practicable. The acquisition is expected to close no later than the first quarter of 2016, subject to obtaining the necessary shareholder approval, receipt of regulatory clearance and customary closing conditions.

EXOR has committed to pay PartnerRe $225 million as a partial reimbursement of the termination fee paid by PartnerRe to AXIS, if certain transaction approvals were not received within 12 months following the signing of the deal, or if there are any non-appealable legal prohibitions to closing.

AXIS Capital has agreed to the termination of its planned merger with PartnerRe, perhaps now leaving the re/insurer vulnerable to other approaches, especially as the termination fee raises its value a little further.

Michael A. Butt, Chairman of the AXIS Capital Board of Directors, commented; “Prior to PartnerRe reaching out to us last December to discuss a combination of our companies, we were confident in continuing with our strategy as a stand-alone company, building our three strong businesses incrementally. We will now proceed with that strategy, with strengthened resolve. We have been very conscious of our responsibilities to our shareholders throughout these negotiations and believe we have demonstrated prudence and financial discipline in our approach.”

Albert Benchimol, President and CEO of AXIS Capital, added; “Our proposed transaction with PartnerRe stood to create a powerful mix of two financially strong and independent companies with compelling insurance/reinsurance franchises. While I am disappointed that the merger will not proceed, I have no doubt that the best days for AXIS Capital, our employees, clients, brokers and shareholders lie ahead. We have built a powerful global platform on which to continue to advance our hybrid insurance model with three diversified businesses in specialty insurance, reinsurance, and accident and health.”

It will be interesting to see whether any buyer for AXIS Capital comes forwards in the coming weeks, or if AXIS itself decided to pursue another company.

EXOR will be delighted that it has finally got an agreement to its offer for PartnerRe, having pursued the reinsurer with increasingly enhanced deal terms for some months now. When the deal completes, assuming nothing gets in its way, EXOR will benefit from a reinsurance business to diversify its holdings and PartnerRe will benefit from being part of a diversified group which should enable it to operate at a lower cost-of-capital.

EXOR will also inherit the third-party reinsurance capital management and insurance-linked investment activities of PartnerRe, which include the Lorenz Re sidecar special purpose insurer, a catastrophe bond fund that PartnerRe has operated since 2006 and some quota share activity with third-party investors.

AXIS has reinstated its capital return plans now that the merger is off.

Benchimol added; “We are prepared to move ahead with our fiscally disciplined growth strategy and a commitment to return excess capital to shareholders in the form of dividends and stock repurchases. Since becoming a public company, we have repurchased approximately 92.8 million shares of AXIS Capital stock for a total of $3.3 billion.

“As we go forward independently, I would like to thank our employees for their diligent efforts throughout the integration planning meetings that took place over the past several months, and for their ongoing focus on the business-of-the-business. We have learned a great deal from this process, and we intend to apply what we have learned to make AXIS Capital a better company in the months and years ahead.”

So finally this reinsurance M&A saga is over, see our long list of articles below for the full history. AXIS can concentrate on progressing its own plans as a standalone re/insurer, while EXOR can plan for its entry into the reinsurance market.

Of course for the market this means that two does not become one, in this case, meaning that there is no reduction in markets or retrocession cedents in this case. That’s also good for Bermuda, where there would have been some job losses as a result of the merger.

It will be interesting to track the potential of PartnerRe under EXOR ownership, when the deal completes. It’s also going to be interested to see who’s next to come into focus in the re/insurance M&A arena.

For the full story see our previous articles, most recent first:

PartnerRe said to contact EXOR, as it seeks to salvage a deal.

Third proxy voting firm favors PartnerRe being bought by EXOR.

AXIS refrains from citing proxy firm inconsistency in second report.

Glass Lewis tells PartnerRe shareholders vote against AXIS deal.

AXIS Capital questions ISS opinion on PartnerRe merger.

ISS tells PartnerRe shareholders not to vote for AXIS merger, plus EXOR’s response.

PartnerRe & AXIS continue to highlight tax risk of EXOR deal.

AXIS: PartnerRe deal superior “immediately & in future” to EXOR deal, halts integration work.

PartnerRe Board says EXOR’s offer likely superior, but still prefers AXIS.

EXOR adds another $3 per common share to PartnerRe offer

Enhanced PartnerRe – AXIS terms weaken merger rationale: Analyst.

PartnerRe and AXIS reveal improved merger terms.

EXOR says PartnerRe & AXIS acknowledge transaction is inferior.

PartnerRe and AXIS Capital evaluate improving merger deal.

As EXOR pursues PartnerRe, AXIS could attract buyer: Macquarie.

Activist Sandell says PartnerRe board misinforming shareholders.

AXIS needs to match, or beat, EXOR’s improved PartnerRe offer.

EXOR enhances deal terms for PartnerRe shareholders.

PartnerRe unimpressed with EXOR’s expanded completion guarantee.

EXOR sweetens PartnerRe offer with completion guarantee.

EXOR says receiving positive response from PartnerRe shareholders, plus updates from both sides.

PartnerRe cites inadequate price, unacceptable risk of EXOR offer.

Confusion over whether Arch is bidding for AXIS, or not.

KBW analysts still give AXIS the edge to win PartnerRe deal.

Arch said to be considering AXIS Capital bid: Reports.

Analysts feel EXOR has improved chance of buying PartnerRe.

EXOR capital structure has no bearing on PartnerRe rating: S&P.

EXOR accuses PartnerRe board of “engineering” AXIS transaction.

PartnerRe Board urges Preferred Shareholders to vote for AXIS merger.

Bermuda court rules against Exor’s shareholder detail request.

PartnerRe shareholders should vote to go with AXIS: KBW analysts.

PartnerRe says Exor’s lawsuit claims “without merit”.

Exor sues to gain access to PartnerRe shareholder details.

PartnerRe-AXIS : $60m fees from third-party reinsurance capital by 2017.

EXOR welcomes PartnerRe shareholder vote, Sandell questions Board.

PartnerRe rejects EXOR again, to proceed with vote on AXIS merger.

EXOR says will engage with PartnerRe board, but not on price.

AXIS prepared to go it alone if PartnerRe deal breaks up.

PartnerRe board wants improved EXOR bid, or it’s back to AXIS.

AXIS unlikely to sweeten PartnerRe offer to match EXOR: Reuters.

Shareholders hold key to PartnerRe’s future, EXOR bid preferred.

EXOR increases offer for PartnerRe, becomes largest shareholder.

Exor to consider increasing bid for PartnerRe, reports.

AXIS, PartnerRe committed on merger. EXOR commits to its offer.

Major shareholder prefers EXOR’s bid for PartnerRe over AXIS’.

EXOR bids $6.4B for PartnerRe, to get into reinsurance.

Register today for ILS Asia 2023, our next insurance-linked securities (ILS) market conference. Held in Singapore, July 13th, 2023.

Artemis ILS Asia 2023 - Insurance-linked securities conference in Singapore

Get a ticket soon to ensure you can attend. Secure your place at the event here!

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.